A critical discovery in cancer research is arising with the use of VHH fragments to re-engage damaged p53. This vital malignant protector protein is frequently inactivated in many kinds of malignancies, resulting https://sociallytraffic.com/story6986914/mini-antibodies-revive-the-p53-protein-a-potential-approach-for-malignant-therapy